Biotech Values

[Biowatch]

drbio45"This market is headed for a huge fall" Check

DNDN #msg-65862672

Dendreon: Parsing Provenge's Problems By Adam Feuerstein
...David Miller of the Biotech Stock Research newsletter is known -- deservedly so -- as the Dendreon axe. He's also a major bull on the stock, except that he's been writing about the risks of reimbursement and "cost density" of Provenge since May. Spot on, David! ...

The "axe"? Is that a bull who doesn't say, "to da moon!"